Mary Tagliaferri

Director Técnico/Científico/I+D en NEKTAR THERAPEUTICS .

Fortuna: 334 250 $ al 30/04/2024

58 años

Health Technology

Consumer Services

Finance

Cargos activos de Mary Tagliaferri

Empresas	Cargo	Inicio	Fin
NEKTAR THERAPEUTICS	Director Técnico/Científico/I+D	17/04/2023	-
NEKTAR THERAPEUTICS	Corporate Officer/Principal	-	17/04/2023
ENZO BIOCHEM, INC.	Director/Miembro de la Junta	17/11/2020	-
	Independent Dir/Board Member	17/11/2020	-
	Presidente	31/01/2022	25/10/2023
Y-MABS THERAPEUTICS, INC.	Director/Miembro de la Junta	29/02/2024	-
Y-MABS THERAPEUTICS, INC.	Independent Dir/Board Member	29/02/2024	-

Empresas	Cargo	Inicio	Fin
RAYZEBIO, INC.	Director/Miembro de la Junta	29/09/2021	26/02/2024
RAYZEBIO, INC.	Independent Dir/Board Member	29/09/2021	26/02/2024
Kanglaite USA, Inc.	Director Técnico/Científico/I+D	01/10/2012	01/06/2014
BIONOVO INC.	Director/Miembro de la Junta	14/04/2011	01/06/2012
	Director Técnico/Científico/I+D	01/02/2002	01/06/2012
	Fundador	01/02/2002	01/06/2012
	Consejero General	01/02/2002	01/06/2012
	Presidente	01/02/2002	01/06/2012
	Secretario Corporativo	01/02/2002	01/06/2012
	Treasurer	01/02/2002	01/06/2012
Lighten Up Enterprises International, Inc.	Director Técnico/Científico/I+D	-	05/07/2005
	Consejero General	-	05/07/2005
	Secretario Corporativo	-	05/07/2005
	Treasurer	-	05/07/2005
ATOSSA THERAPEUTICS, INC.	Director/Miembro de la Junta	06/10/2010	-

Cornell University	Undergraduate Degree
The University of California, San Francisco	Doctorate Degree
American College of Traditional Chinese Medicine	Graduate Degree

Internacional

Estados Unidos

Operativa

Director/Board Member	5
Chief Tech/Sci/R&D Officer	4
Independent Dir/Board Member	3

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	3
Lighten Up Enterprises International, Inc.	Finance
Bionovo, Inc. Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA.	Health Technology
Kanglaite USA, Inc.